nach oben

Erschienen in:

01.06.2019 | Case report

Pembrolizumab

Skin rash: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective review of five patients, who were diagnosed with advanced pulmonary sarcomatoid carcinoma (PSC) between June 2015 and June 2018, a 57-year-old man was described, who developed a skin rash during treatment with pembrolizumab for stage IV PSC. …

Sukrithan V, et al. Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma. Clinical Lung Cancer 20: e242-e246, No. 3, May 2019. Available from: URL: http://doi.org/10.1016/j.cllc.2018.12.013 - USA

Titel: Pembrolizumab
Skin rash: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-64099-8

Nitrous oxide toxicity

Case report

Antineoplastics/folinic acid

Case report

Fingolimod

Case report

Bupivacaine/epinephrine/lidocaine

Case report

Antineoplastics

Case report

Sirolimus

Case report

Springer Medizin

Pembrolizumab

Skin rash: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Nitrous oxide toxicity

Antineoplastics/folinic acid

Fingolimod

Bupivacaine/epinephrine/lidocaine

Antineoplastics

Sirolimus

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Nitrous oxide toxicity

Antineoplastics/folinic acid

Fingolimod

Bupivacaine/epinephrine/lidocaine

Antineoplastics

Sirolimus